By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Actinium Pharmaceuticals, Inc. 

501 Fifth Avenue

New York City  New York  10017  U.S.A.
Phone: 646-459-4201 Fax: n/a


Company News
Actinium (ATNM.OB) Further Strengthens Clinical Development Team With Senior Hire To Support Later-Stage Clinical Trials 11/29/2016 8:14:01 AM
Actinium (ATNM.OB) Announces Notice Of Allowance For U.S. Patent Related To Actimab-A 11/14/2016 8:09:58 AM
Actinium (ATNM.OB) Announces Key Hire In Clinical Supply Chain Organization As Company Expands To Accommodate Continued Growth 10/31/2016 8:06:49 AM
Actinium (ATNM.OB) Initiates Pursuit Of Scientific Advice For Iomab-B From The EMA 10/25/2016 8:27:45 AM
Actinium (ATNM.OB) Granted Orphan Designation From The EMA For Iomab-B 10/18/2016 10:11:02 AM
Actinium (ATNM.OB) Announces Closing Of Public Offering Of Common Stock 10/5/2016 8:04:51 AM
Actinium (ATNM.OB) Announces Pricing of Public Offering of Common Stock 9/29/2016 11:34:44 AM
Actinium (ATNM.OB) Announces Initiation Of Phase II Clinical Trial Of Actimab-A In Patients Newly Diagnosed With Acute Myeloid Leukemia Over Age 60 9/27/2016 7:43:59 AM
Actinium (ATNM.OB) To Sponsor And Participate In Be The Match Walk+Run To Raise Awareness For Bone Marrow Transplant 9/26/2016 7:52:49 AM
Actinium (ATNM.OB) To Host Webinar To Provide Update On Actimab-A Phase II Clinical Trial 9/21/2016 10:38:06 AM